The Oncosearch | Oncotarget

DPA shows comparable chemotherapy sensitizing effects as EPA upon cellular incorporation in tumor cells Research Paper

Francina J. Dijk, Miriam van Dijk, Bram Dorresteijn, Klaske van Norren

Published Oct 15, 2019 · Vol. 10, No. 57 · pp. 5983-5992

Keywords: DPA, fish oil, nutrition, chemotherapy, cancer

Malignant ascites: a source of therapeutic protein against ovarian cancer? Research Paper

Pascale Ribaux, Aurore Britan, Gabriele Thumann, Florence Delie, Patrick Petignat, Marie Cohen

Published Oct 15, 2019 · Vol. 10, No. 57 · pp. 5894-5905

Keywords: ascites, PEDF, sleeping beauty transposon, ovarian cancer, tumor development

Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report Case Report

Mayank Rao, Meenakshi Bhattacharjee, Scott Shepard, Sigmund Hsu

Published Oct 15, 2019 · Vol. 10, No. 57 · pp. 6038-6042

Keywords: papillary, craniopharyngioma, BRAF V600E, dabrafenib, neuro-oncology

The proteasome deubiquitinase inhibitor bAP15 downregulates TGF-β/Smad signaling and induces apoptosis via UCHL5 inhibition in ovarian cancer Research Paper

Shiho Fukui, Kazunori Nagasaka, Yuko Miyagawa, Ryoko Kikuchi-Koike, Yoshiko Kawata, Ranka Kanda, Takayuki Ichinose, Takeru Sugihara, Haruko Hiraike, Osamu Wada-Hiraike, Yuko Sasajima, Takuya Ayabe

Published Oct 15, 2019 · Vol. 10, No. 57 · pp. 5932-5948

Keywords: ovarian cancer, bAP15, TGF-β/Smad signaling, UCHL5, apoptosis

Targeting glutaminase1 and synergizing with clinical drugs achieved more promising antitumor activity on multiple myeloma Research Paper

Qiang Qiu, Mengyuan Li, Linyu Yang, Minghai Tang, Li Zheng, Fang Wang, Huandi Qiu, Cailing Liang, Ning Li, Dongni Yi, Yuyao Yi, Cong Pan, Shengyong Yang, Lijuan Chen, Yiguo Hu

Published Oct 15, 2019 · Vol. 10, No. 57 · pp. 5993-6005

Keywords: glutaminase1, multiple myeloma, BPTES, cMYC/KRAS12V-transduced plasmacytoma, mouse model

T-helper 1-type cytokines induce apoptosis and loss of HER-family oncodriver expression in murine and human breast cancer cells Research Paper

Prachi Namjoshi, Lori Showalter, Brian J. Czerniecki, Gary K. Koski

Published Oct 15, 2019 · Vol. 10, No. 57 · pp. 6006-6020

Keywords: apoptosis, HER-2, T-helper 1, IFN-γ, TNF-α

Epigenetic silencing of HOPX is critically involved in aggressive phenotypes and patient prognosis in papillary thyroid cancer Research Paper

Yosuke Ooizumi, Hiroshi Katoh, Mitsuo Yokota, Masahiko Watanabe, Keishi Yamashita

Published Oct 15, 2019 · Vol. 10, No. 57 · pp. 5906-5918

Keywords: HOPX, papillary thyroid cancer, epigenetic silencing, promoter methylation

Splicing regulatory factors in breast cancer hallmarks and disease progression Review

Esmee Koedoot, Liesanne Wolters, Bob van de Water, Sylvia E. Le Dévédec

Published Oct 15, 2019 · Vol. 10, No. 57 · pp. 6021-6037

Keywords: hallmarks of cancer, breast cancer, alternative splicing, splice factors, RNA sequencing

Assessment of circularized E7 RNA, GLUT1, and PD-L1 in anal squamous cell carcinoma Research Paper

Bahir H. Chamseddin, Eunice E. Lee, Jiwoong Kim, Xiaowei Zhan, Rong Yang, Kathleen M. Murphy, Cheryl Lewis, Gregory A. Hosler, Suntrea T. Hammer, Richard C. Wang

Published Oct 15, 2019 · Vol. 10, No. 57 · pp. 5958-5969

Keywords: anal squamous cell carcinoma, circular RNA, GLUT1, human papillomavirus, PD-L1

Overcoming heterogenity in imatinib-resistant gastrointestinal stromal tumor Editorial

César Serrano, Jonathan A. Fletcher

Published Oct 14, 2019 · Vol. 10, No. 59 · pp. 6286-6287

Keywords: GIST, imatinib, sunitinib, regorafenib, therapeutic combination

Tumor necrosis factor related apoptosis inducing ligand (TRAIL) regulates deubiquitinase USP5 in tumor cells Research Paper

Harish Potu, Malathi Kandarpa, Luke F. Peterson, Nicholas J. Donato, Moshe Talpaz

Published Oct 8, 2019 · Vol. 10, No. 56 · pp. 5745-5754

Keywords: USP5, ubiquitin, TRAIL, DUB inhibitor, G9

Fewer actionable mutations but higher tumor mutational burden characterizes NSCLC in black patients at an urban academic medical center Research Paper

Noura J. Choudhury, Mansooreh Eghtesad, Sabah Kadri, John Cursio, Lauren Ritterhouse, Jeremy Segal, Aliya Husain, Jyoti D. Patel

Published Oct 8, 2019 · Vol. 10, No. 56 · pp. 5817-5823

Keywords: non-small cell lung cancer, healthcare disparities, targeted therapies, immunotherapies, biomarkers

Clinicopathological correlation of immune response in human cancers Research Paper

Yuexin Liu

Published Oct 8, 2019 · Vol. 10, No. 56 · pp. 5859-5870

Keywords: clinicopathological characteristics, immune response, immunogenicity, cancer

Mutation of the co-chaperone Tsc1 in bladder cancer diminishes Hsp90 acetylation and reduces drug sensitivity and selectivity Research Paper

Mark R. Woodford, Michael Hughes, Rebecca A. Sager, Sarah J. Backe, Alexander J. Baker-Williams, Michael S. Bratslavsky, Joseph M. Jacob, Oleg Shapiro, Michael Wong, Gennady Bratslavsky, Dimitra Bourboulia, Mehdi Mollapour

Published Oct 8, 2019 · Vol. 10, No. 56 · pp. 5824-5834

Keywords: tuberous sclerosis complex (TSC), Tsc1 (Hamartin), Tsc2 (Tuberin), heat shock protein (Hsp90), bladder cancer

A side-by-side evaluation of [¹⁸F]FDOPA enantiomers for non-invasive detection of neuroendocrine tumors by positron emission tomography Research Paper

Athira Narayan, Yu Yan, Ala Lisok, Mary Brummet, Martin G. Pomper, Wojciech G. Lesniak, Robert F. Dannals, Vanessa F. Merino, Babak Behnam Azad

Published Oct 8, 2019 · Vol. 10, No. 56 · pp. 5731-5744

Keywords: FDOPA, PET, neuroendocrine tumors, Fluorine-18, molecular imaging

Correction: ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation Correction

Aaditya Khatri, Jing Jin Gu, Courtney M. McKernan, Xia Xu, Ann Marie Pendergast

Published Oct 3, 2019 · Vol. 10, No. 57 · pp. 6045-6046

Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcoma Research Paper

Nathan D. Seligson, Colin W. Stets, Bryce W. Demoret, Achal Awasthi, Nicholas Grosenbacher, Reena Shakya, John L. Hays, James L. Chen

Published Oct 1, 2019 · Vol. 10, No. 55 · pp. 5671-5679

Keywords: dedifferentiated liposarcomas, MDM2, HDAC2, romidepsin, MI-192

Upregulation of C1-inhibitor in pancreatic cancer Research Paper

Kurt Osther, Karolina Förnvik, Emma Liljedahl, Leif G. Salford, Henrietta Nittby Redebrandt

Published Oct 1, 2019 · Vol. 10, No. 55 · pp. 5703-5712

Keywords: complement system, C1-inhibitor, pancreatic cancer, immunotherapy, cancer

Comparison of different semi-automated cfDNA extraction methods in combination with UMI-based targeted sequencing Research Paper

Anna Streubel, Albrecht Stenzinger, Susann Stephan-Falkenau, Jens Kollmeier, Daniel Misch, Torsten Gerriet Blum, Torsten Bauer, Olfert Landt, Alexander Am Ende, Peter Schirmacher, Thomas Mairinger, Volker Endris

Published Oct 1, 2019 · Vol. 10, No. 55 · pp. 5690-5702

Keywords: lung cancer, liquid biopsy, cfDNA, molecular diagnostics, T790M

Clinical significance of evaluating hormone receptor and HER2 protein using cell block against metastatic breast cancer: a multi-institutional study Research Paper

Akira Matsui, Yuya Murata, Norikazu Masuda, Kiyoshi Mori, Masato Takahashi, Katsushige Yamashiro, Kenjirou Aogi, Shigeto Maeda, Masahiro Itou, Shinji Ozaki, Kazuya Kuraoka, Yasuyuki Satou, Shu Ichihara, Eriko Tokunaga, Kenichi Taguchi, Takanori Watanabe, Hiroyoshi Suzuki, Aiko Nagayama, Rieko Nishimura

Published Oct 1, 2019 · Vol. 10, No. 55 · pp. 5680-5689

Keywords: metastatic breast cancer, receptor discordance, cell block, cytological specimen, prognosis

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

DPA shows comparable chemotherapy sensitizing effects as EPA upon cellular incorporation in tumor cells Research Paper

Malignant ascites: a source of therapeutic protein against ovarian cancer? Research Paper

Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report Case Report

The proteasome deubiquitinase inhibitor bAP15 downregulates TGF-β/Smad signaling and induces apoptosis via UCHL5 inhibition in ovarian cancer Research Paper

Targeting glutaminase1 and synergizing with clinical drugs achieved more promising antitumor activity on multiple myeloma Research Paper

T-helper 1-type cytokines induce apoptosis and loss of HER-family oncodriver expression in murine and human breast cancer cells Research Paper

Epigenetic silencing of HOPX is critically involved in aggressive phenotypes and patient prognosis in papillary thyroid cancer Research Paper

Splicing regulatory factors in breast cancer hallmarks and disease progression Review

Assessment of circularized E7 RNA, GLUT1, and PD-L1 in anal squamous cell carcinoma Research Paper

Overcoming heterogenity in imatinib-resistant gastrointestinal stromal tumor Editorial

Tumor necrosis factor related apoptosis inducing ligand (TRAIL) regulates deubiquitinase USP5 in tumor cells Research Paper

Fewer actionable mutations but higher tumor mutational burden characterizes NSCLC in black patients at an urban academic medical center Research Paper

Clinicopathological correlation of immune response in human cancers Research Paper

Mutation of the co-chaperone Tsc1 in bladder cancer diminishes Hsp90 acetylation and reduces drug sensitivity and selectivity Research Paper

A side-by-side evaluation of [¹⁸F]FDOPA enantiomers for non-invasive detection of neuroendocrine tumors by positron emission tomography Research Paper

Correction: ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation Correction

Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcoma Research Paper

Upregulation of C1-inhibitor in pancreatic cancer Research Paper

Comparison of different semi-automated cfDNA extraction methods in combination with UMI-based targeted sequencing Research Paper

Clinical significance of evaluating hormone receptor and HER2 protein using cell block against metastatic breast cancer: a multi-institutional study Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

DPA shows comparable chemotherapy sensitizing effects as EPA upon cellular incorporation in tumor cells Research Paper

Malignant ascites: a source of therapeutic protein against ovarian cancer? Research Paper

Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report Case Report

The proteasome deubiquitinase inhibitor bAP15 downregulates TGF-β/Smad signaling and induces apoptosis via UCHL5 inhibition in ovarian cancer Research Paper

Targeting glutaminase1 and synergizing with clinical drugs achieved more promising antitumor activity on multiple myeloma Research Paper

T-helper 1-type cytokines induce apoptosis and loss of HER-family oncodriver expression in murine and human breast cancer cells Research Paper

Epigenetic silencing of HOPX is critically involved in aggressive phenotypes and patient prognosis in papillary thyroid cancer Research Paper

Splicing regulatory factors in breast cancer hallmarks and disease progression Review

Assessment of circularized E7 RNA, GLUT1, and PD-L1 in anal squamous cell carcinoma Research Paper

Overcoming heterogenity in imatinib-resistant gastrointestinal stromal tumor Editorial

Tumor necrosis factor related apoptosis inducing ligand (TRAIL) regulates deubiquitinase USP5 in tumor cells Research Paper

Fewer actionable mutations but higher tumor mutational burden characterizes NSCLC in black patients at an urban academic medical center Research Paper

Clinicopathological correlation of immune response in human cancers Research Paper

Mutation of the co-chaperone Tsc1 in bladder cancer diminishes Hsp90 acetylation and reduces drug sensitivity and selectivity Research Paper

A side-by-side evaluation of [18F]FDOPA enantiomers for non-invasive detection of neuroendocrine tumors by positron emission tomography Research Paper

Correction: ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation Correction

Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcoma Research Paper

Upregulation of C1-inhibitor in pancreatic cancer Research Paper

Comparison of different semi-automated cfDNA extraction methods in combination with UMI-based targeted sequencing Research Paper

Clinical significance of evaluating hormone receptor and HER2 protein using cell block against metastatic breast cancer: a multi-institutional study Research Paper

A side-by-side evaluation of [¹⁸F]FDOPA enantiomers for non-invasive detection of neuroendocrine tumors by positron emission tomography Research Paper